Announced Thu, 21 May · 16:56 IST

Appointment of Secretarial Auditor

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ganga Pharmaceuticals Ltd's Board of Directors, at its meeting on May 21, 2026, approved the appointment of M/s. D Maurya & Associates, a Mumbai-based practicing company secretary firm, as the Secretarial Auditor for financial year 2026-27. The appointment was made based on the recommendation of the Audit Committee. Mr. Dhirendra Maurya, an Associate Member of ICSI with expertise in secretarial audits, due diligence, and SEBI LODR compliance, leads the firm. A secretarial auditor is an independent external reviewer and not a Key Managerial Personnel (KMP) of the company.

Likely market impact

This is a routine appointment of an independent external auditor and has no direct impact on the company's leadership or governance structure. It reflects normal compliance with SEBI Listing Regulations and is neutral for shareholders.